Aspero Medical in the News
September 26, 2023
Aspero Medical has been accepted into the Biomedical Stream at Creative Destruction Lab (CDL)
Creative Destruction Lab supports the commercialization of early stage companies. Working with CDL-Vancouver, Aspero Medical will continue to enable Third-Space Endoscopy and advance flexible endoscopy intervention.
August 31, 2023
FDA Clears Aspero Medical’s Revolutionary Pillar Balloon Enteroscopy Overtube
Aspero Medical has received clearance from the FDA to market and sell the Ancora-SB small bowel balloon overtube that incorporates the company’s patented Pillar micro-texture balloon technology. Ancora-SB is cleared for use during small bowel enteroscopy procedures.
Destination Startup is a collaboration among leading research universities and federal laboratories across the Rocky Mountain region to showcase the best companies from our innovation ecosystem.
December 29, 2020
Aspero Medical Completes Animal Clinical Study and Announces the Formation of Clinical Advisory Board
Animal clinical study finds no histopathological difference between smooth silicone balloon and Aspero's balloon with Pillar technology. Dr. Steven Edmundowicz, Chief Clinical Officer, is joined by Dr. John Vargo (Cleveland Clinic) and Dr. Andrew Ross (Virginia Mason) on Aspero's Clinical Advisory Board.
July 23, 2018
Innosphere Fund Invests in University of Colorado Medical Device Start Up Company
The Innosphere Fund announces their investment in Boulder-based start-up company, Aspero Medical Corporation, a company with unique intellectual property for endoscopy procedures that was developed at the University of Colorado.